Total Payments
$12,449
2024 Payments
$6,063
Companies
24
Transactions
386
Medicare Patients
568
Medicare Billing
$87,241
Payment Breakdown by Category
Food & Beverage$10,058 (80.8%)
Other$2,000 (16.1%)
Education$300.31 (2.4%)
Travel$89.95 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,058 | 378 | 80.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 2 | 16.1% |
| Education | $300.31 | 4 | 2.4% |
| Travel and Lodging | $89.95 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,834 | 143 | $0 (2024) |
| Amgen Inc. | $1,613 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,064 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $730.68 | 13 | $0 (2024) |
| PFIZER INC. | $393.83 | 26 | $0 (2024) |
| Lilly USA, LLC | $367.57 | 13 | $0 (2024) |
| Novo Nordisk Inc | $343.87 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $283.63 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $277.79 | 6 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $277.56 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,063 | 161 | ABBVIE INC. ($3,090) |
| 2023 | $3,829 | 152 | ABBVIE INC. ($1,530) |
| 2022 | $2,516 | 72 | ABBVIE INC. ($1,214) |
| 2021 | $40.06 | 1 | BIOTRONIK INC. ($40.06) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.00 | General |
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Biological | ||||||
| 12/09/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Analgesic | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $5.80 | General |
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: GI | ||||||
| 10/21/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: GALLSTONES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 256 | 612 | $122,665 | $45,225 |
| 2022 | 10 | 219 | 363 | $86,122 | $29,887 |
| 2021 | 4 | 93 | 158 | $29,980 | $12,129 |
Total Patients
568
Total Services
1,133
Medicare Billing
$87,241
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 289 | $44,700 | $19,793 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 184 | $32,950 | $17,792 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $18,014 | $3,610 | 20.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $10,755 | $1,386 | 12.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 27 | $3,375 | $1,208 | 35.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 15 | $1,875 | $958.05 | 51.1% |
| 29540 | Placement of strapping to ankle or foot | Office | 2023 | 14 | 14 | $8,876 | $291.98 | 3.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 16 | $320.00 | $134.40 | 42.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 11 | 12 | $1,800 | $50.81 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 174 | $28,350 | $12,290 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 54 | $10,950 | $5,241 | 47.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $23,412 | $3,679 | 15.7% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 12 | 12 | $3,600 | $2,510 | 69.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $9,310 | $2,109 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 14 | $3,500 | $1,777 | 50.8% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 11 | 14 | $3,500 | $1,332 | 38.1% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 13 | 15 | $3,000 | $913.76 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 12 | $240.00 | $35.76 | 14.9% |
| 91301 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use | Office | 2022 | 12 | 13 | $260.00 | $0.13 | 0.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 80 | $13,350 | $5,656 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 28 | $4,900 | $2,613 | 53.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 28 | 29 | $7,530 | $2,516 | 33.4% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2021 | 11 | 21 | $4,200 | $1,343 | 32.0% |
About Stephanie Khan
Stephanie Khan is a Obstetric, Inpatient healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1366961526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Khan has received a total of $12,449 in payments from pharmaceutical and medical device companies, with $6,063 received in 2024. These payments were reported across 386 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($10,058).
As a Medicare-enrolled provider, Khan has provided services to 568 Medicare beneficiaries, totaling 1,133 services with total Medicare billing of $87,241. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetric, Inpatient
- Other Specialties Inpatient|Family Medicine|Family
- Location Forest Hills, NY
- Active Since 09/19/2017
- Last Updated 01/24/2025
- Taxonomy Code 163WX0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366961526
Products in Payments
- VRAYLAR (Drug) $3,623
- QULIPTA (Drug) $1,174
- Otezla (Drug) $988.48
- Repatha (Biological) $624.30
- AUSTEDO (Drug) $592.49
- UBRELVY (Drug) $385.06
- Austedo XR (Drug) $366.78
- AIRSUPRA (Drug) $348.65
- NURTEC ODT (Drug) $319.50
- CREON (Drug) $298.59
- INGREZZA (Drug) $283.63
- ZTLido (Drug) $277.56
- RELTONE 200 MG (Drug) $221.74
- Linzess (Drug) $206.89
- LINZESS (Drug) $206.24
- BREZTRI (Drug) $170.02
- CAPLYTA (Drug) $166.36
- AMYVID (Drug) $165.45
- OPZELURA (Drug) $154.26
- LOKELMA (Drug) $153.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.